(MedPage Today) — The FDA finalized clinical guidance for psychedelic drug developers and scheduled a public hearing for September to discuss potential therapeutic uses. Meanwhile, HHS and the VA are partnering to speed up the research and development…
Source: MedPage Today — Headlines
